Dr. Graham is Professor of Medicine and Microbiology, Biochemistry, & Immunology and Senior Advisor for Global Health Equity at Morehouse School of Medicine in Atlanta. He is the former deputy director of the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). During his tenure at the VRC, Graham also served as chief of the Viral Pathogenesis Laboratory.  Dr. Graham is an immunologist, virologist, and clinical trials physician whose primary interests are viral pathogenesis, immunity, and vaccine development.

 

His work is focused on respiratory syncytial virus (RSV), influenza, coronaviruses, HIV, and other emerging viral diseases. After graduating from Rice University, Houston, TX, he obtained his MD from the University of Kansas School of Medicine in 1979. He then completed residency and two chief residencies in Internal Medicine, a fellowship in Infectious Diseases, and a PhD in Microbiology & Immunology at Vanderbilt University School of Medicine, Nashville, TN, where he rose to the rank of Professor of Medicine with a joint appointment in the Department of Microbiology & Immunology. In 2000, he became one of the founding investigators for the NIAID VRC at NIH, where he is now the Deputy Director and Chief of the Viral Pathogenesis Laboratory, and oversees the advanced development of VRC candidate vaccine products.

 

He serves as a consultant for organizations involved in vaccine development for HIV, Tb, malaria, RSV, and emerging viral pathogens. His laboratory investigates basic mechanisms by which T cells affect viral clearance and immunopathology, explores mechanisms of antibody-mediated viral neutralization, and develops vaccine approaches against respiratory virus infections and emerging viral diseases.